Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dermatech is a South Korean medical device and biotechnology company specializing in microneedle technology for dermatological and drug delivery applications. The company is a pioneer in the development of the Microneedle Therapy System (MTS) and Auto Microneedle Therapy System (AMTS), which are designed to enhance the transdermal delivery of active ingredients and stimulate natural skin regeneration. Dermatech's product portfolio includes professional-grade microneedling devices, consumer skincare tools, and specialized serums. Their technology is widely used in clinical settings for treating skin aging, scars, and hair loss, and the company continues to innovate in the field of minimally invasive skin treatments and transdermal drug delivery platforms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dermatech.